Uncovering Potential: Altimmune's Earnings Preview

Altimmune ALT is set to give its latest quarterly earnings report on Tuesday, 2025-08-12. Here's what investors need to know before the announcement.

Analysts estimate that Altimmune will report an earnings per share (EPS) of $-0.32.

Anticipation surrounds Altimmune's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings Track Record

During the last quarter, the company reported an EPS beat by $0.09, leading to a 1.04% drop in the share price on the subsequent day.

Here's a look at Altimmune's past performance and the resulting price change:

Performance of Altimmune Shares

Shares of Altimmune were trading at $3.45 as of August 08. Over the last 52-week period, shares are down 46.75%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Altimmune visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.